Crinetics Pharmaceuticals (CRNX) Other Accumulated Expenses (2017 - 2025)
Crinetics Pharmaceuticals (CRNX) recorded Other Accumulated Expenses of $1.8 million in Q2 2025, up 66.4% from $1.08 million a year earlier and up 8.0% from the prior quarter.
Powered by 
Analysis
Crinetics Pharmaceuticals (CRNX) Other Accumulated Expenses (2017 - 2025) Analysis & Trends
At the end of FY2024, Crinetics Pharmaceuticals reported Other Accumulated Expenses of $901,000, down 72.4% from FY2023.
- Annual Other Accumulated Expenses has a five-year compound annual growth rate of 4.5% (FY2019 to FY2024).
- Across earlier years, Other Accumulated Expenses came in at $3.27 million in FY2023 (+875.2%), $335,000 in FY2022 (-64.3%), $939,000 in FY2021 (+12.5%) and $835,000 in FY2020 (+15.3%).
- The Q2 2025 figure is the highest quarterly Other Accumulated Expenses since Q4 2023.
- On a year-over-year basis, Other Accumulated Expenses rose in five of the last eight quarters, with growth averaging 155.9%.
- Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 875.2% in Q4 2023, against a decline of 72.4% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.67 million (Q1 2025), $901,000 (Q4 2024) and $507,000 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.67 Mn |
| Dec 31, 2024 | 901,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 489,000.00 |
| Dec 31, 2023 | 3.27 Mn |
| Sep 30, 2023 | 991,000.00 |
| Jun 30, 2023 | 522,000.00 |
| Mar 31, 2023 | 977,000.00 |
| Dec 31, 2022 | 335,000.00 |
| Sep 30, 2022 | 433,000.00 |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 965,000.00 |
| Dec 31, 2021 | 939,000.00 |
| Sep 30, 2021 | 912,000.00 |
| Jun 30, 2021 | 886,000.00 |
| Mar 31, 2021 | 860,000.00 |
| Dec 31, 2020 | 835,000.00 |
| Sep 30, 2020 | 810,000.00 |
API Access
Crinetics Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CRNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "CRNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CRNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();